Viewing Study NCT02038933


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-02-21 @ 10:02 AM
Study NCT ID: NCT02038933
Status: COMPLETED
Last Update Posted: 2021-10-14
First Post: 2014-01-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)
Sponsor:
Organization: